293 related articles for article (PubMed ID: 33594488)
1. Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial.
Nordklint AK; Almdal TP; Vestergaard P; Lundby-Christensen L; Boesgaard TW; Breum L; Gade-Rasmussen B; Sneppen SB; Gluud C; Hemmingsen B; Perrild H; Madsbad S; Mathiesen ER; Tarnow L; Thorsteinsson B; Vestergaard H; Lund SS; Eiken P
Osteoporos Int; 2021 Sep; 32(9):1837-1848. PubMed ID: 33594488
[TBL] [Abstract][Full Text] [Related]
2. The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.
Nordklint AK; Almdal TP; Vestergaard P; Lundby-Christensen L; Boesgaard TW; Breum L; Gade-Rasmussen B; Sneppen SB; Gluud C; Hemmingsen B; Jensen T; Krarup T; Madsbad S; Mathiesen ER; Perrild H; Tarnow L; Thorsteinsson B; Vestergaard H; Lund SS; Eiken P
Osteoporos Int; 2018 Nov; 29(11):2517-2526. PubMed ID: 30027438
[TBL] [Abstract][Full Text] [Related]
3. Aged-Related Changes in Body Composition and Association between Body Composition with Bone Mass Density by Body Mass Index in Chinese Han Men over 50-year-old.
Jiang Y; Zhang Y; Jin M; Gu Z; Pei Y; Meng P
PLoS One; 2015; 10(6):e0130400. PubMed ID: 26090818
[TBL] [Abstract][Full Text] [Related]
4. Influence of orlistat on bone turnover and body composition.
Gotfredsen A; Westergren Hendel H; Andersen T
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1154-60. PubMed ID: 11486790
[TBL] [Abstract][Full Text] [Related]
5. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
[TBL] [Abstract][Full Text] [Related]
6. Does high-intensity resistance training maintain bone mass during moderate weight loss in older overweight adults with type 2 diabetes?
Daly RM; Dunstan DW; Owen N; Jolley D; Shaw JE; Zimmet PZ
Osteoporos Int; 2005 Dec; 16(12):1703-12. PubMed ID: 15937634
[TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin.
Ljunggren Ö; Bolinder J; Johansson L; Wilding J; Langkilde AM; Sjöström CD; Sugg J; Parikh S
Diabetes Obes Metab; 2012 Nov; 14(11):990-9. PubMed ID: 22651373
[TBL] [Abstract][Full Text] [Related]
8. Relationship between body composition and bone mass in normal-weight and overweight adolescents.
Bim MA; Pinto AA; de Angelo HCC; Gonzaga I; Guimarães ACA; Felden ÉPG; de Carvalho WRG; Hind K; Pelegrini A
PeerJ; 2022; 10():e14108. PubMed ID: 36348662
[TBL] [Abstract][Full Text] [Related]
9. Lean mass is the strongest predictor of bone mineral content in type-2 diabetes and normal individuals: an eastern India perspective.
Maisnam I; Dutta D; Mukhopadhyay S; Chowdhury S
J Diabetes Metab Disord; 2014; 13(1):90. PubMed ID: 25229052
[TBL] [Abstract][Full Text] [Related]
10. Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial.
Bo S; Gambino R; Ponzo V; Cioffi I; Goitre I; Evangelista A; Ciccone G; Cassader M; Procopio M
Nutr Diabetes; 2018 Sep; 8(1):51. PubMed ID: 30237505
[TBL] [Abstract][Full Text] [Related]
11. Validation of a dual energy X-ray absorptiometer: measurement of bone mass and soft tissue composition.
Madsen OR; Jensen JE; Sørensen OH
Eur J Appl Physiol Occup Physiol; 1997; 75(6):554-8. PubMed ID: 9202954
[TBL] [Abstract][Full Text] [Related]
12. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin.
Bolinder J; Ljunggren Ö; Kullberg J; Johansson L; Wilding J; Langkilde AM; Sugg J; Parikh S
J Clin Endocrinol Metab; 2012 Mar; 97(3):1020-31. PubMed ID: 22238392
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
[TBL] [Abstract][Full Text] [Related]
14. Influence of the weight status on bone mineral content and bone mineral density in a group of Lebanese adolescent girls.
El Hage R; Jacob C; Moussa E; Groussard C; Pineau JC; Benhamou CL; Jaffré C
Joint Bone Spine; 2009 Dec; 76(6):680-4. PubMed ID: 19945325
[TBL] [Abstract][Full Text] [Related]
15. Excess body fat negatively affects bone mass in adolescents.
Mosca LN; Goldberg TB; da Silva VN; da Silva CC; Kurokawa CS; Bisi Rizzo AC; Corrente JE
Nutrition; 2014; 30(7-8):847-52. PubMed ID: 24985003
[TBL] [Abstract][Full Text] [Related]
16. In vivo whole body and appendicular bone mineral density in rats: a dual energy X-ray absorptiometry study.
Karahan S; Kincaid SA; Lauten SD; Wright JC
Comp Med; 2002 Apr; 52(2):143-51. PubMed ID: 12022394
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of lifestyle and metformin interventions in DPP on bone density.
Schwartz AV; Pan Q; Aroda VR; Crandall JP; Kriska A; Piromalli C; Wallia A; Temprosa M; Florez H;
Osteoporos Int; 2021 Nov; 32(11):2279-2287. PubMed ID: 34086101
[TBL] [Abstract][Full Text] [Related]
18. Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus.
Nordklint AK; Almdal TP; Vestergaard P; Lundby-Christensen L; Jørgensen NR; Boesgaard TW; Breum L; Gade-Rasmussen B; Sneppen SB; Gluud C; Hemmingsen B; Krarup T; Madsbad S; Mathiesen ER; Perrild H; Tarnow L; Thorsteinsson B; Vestergaard H; Lund SS; Eiken P
Calcif Tissue Int; 2020 Aug; 107(2):160-169. PubMed ID: 32468187
[TBL] [Abstract][Full Text] [Related]
19. METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT GAIN.
Mogul H; Freeman R; Nguyen K
Endocr Pract; 2016 May; 22(5):575-86. PubMed ID: 26789348
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
Avilés-Santa L; Sinding J; Raskin P
Ann Intern Med; 1999 Aug; 131(3):182-8. PubMed ID: 10428734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
